期刊文献+

代谢相关脂肪性肝病的发病机制及其与肠道真菌群关系的研究进展 被引量:1

Research progress on the pathogenesis of metabolic-associated fatty liver disease and its relationship with intestinal fungal community
下载PDF
导出
摘要 代谢相关脂肪性肝病(MAFLD)对人类健康所构成的威胁不容忽视,现代医学关于MAFLD的发病机制的探讨较多,该文回顾了MAFLD的发病机制及其与肠道真菌群的关系,并讨论了肠道真菌群可能影响疾病进展的机制。控制肠道真菌群的策略可能被开发用于治疗或预防肝脏疾病。 The threat of metabolic-associated fatty liver disease(MAFLD)to human health cannot be ignored.There are many discussions about the pathogenesis of MAFLD in modern medicine.In this paper,we review the pathogenesis of MAFLD and its relationship with intestinal fungal community,and discuss the mechanisms by which the intestinal fungal community may influence the disease progression.Strategies to control the intestinal fungal community may be developed to treat or prevent liver disease.
作者 谢娇娇 王莉 何燕芳(综述) 马燕花(审校) XIE Jiao-jiao;WANG Li;HE Yan-fang(First School of Clinical Medicine,Gansu Uni-versity of Chinese Medicine,Lanzhou 730000,China)
出处 《中国临床新医学》 2022年第8期765-769,共5页 CHINESE JOURNAL OF NEW CLINICAL MEDICINE
基金 国家自然科学基金地区基金项目(编号:81860821)。
关键词 代谢相关脂肪性肝病 发病机制 肠道真菌群 肠道细菌群 Metabolic-associated fatty liver disease(MAFLD) Pathogenesis Intestinal fungal community Intestinal bacterial flora
  • 相关文献

参考文献6

二级参考文献48

  • 1王建超,银艳桃,廖健思,朱晓伟,侯太源,文彬,梁健,邓鑫.天然牛磺酸对肝纤维化大鼠肿瘤坏死因子-α表达的影响[J].辽宁中医杂志,2020,47(1):191-194. 被引量:3
  • 2张晓丽.桂枝茯苓丸防治肝纤维化的实验研究[J].湖北中医学院学报,2005,7(1):16-18. 被引量:9
  • 3范建高.非酒精性脂肪性肝病的流行率[J].中国医师进修杂志(内科版),2006,29(9):1-2. 被引量:33
  • 4池肇春.非酒精性脂肪性肝病的危险因素[J].中国医师进修杂志(内科版),2006,29(9):3-4. 被引量:15
  • 5Harrison SA, Kadakia S, Lang KA, et al. Nonalcoholic steatohepatitis: what we know in the new millennium. Am J Gastro enterol, 2002, 97: 2714-2724.
  • 6Clark JM, Brancati FL, Diehl AM. Nonalcoholic fatty liver dis ease. Gastroenterology, 2002, 122: 1649-1657.
  • 7Kumar KS, Malet PF. Nonalcoholic steatohepatitis. Mayo Clic Proc, 2000, 75: 733-739.
  • 8Day C, James O. Steatohepatitis: A tale of two ''hits''? Gastroenterology, 1998, 114: 842-845.
  • 9Marchesini G, Brizi M, Morselli- Labate AM, et al. Association of nonalcoholic fatty liver disease with insulin resistance.Am J Med, 1999, 107: 450-455.
  • 10Chitturi S, Abeygunasekera S, Farrell GC, et al. NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology, 2002,35: 373-379.

共引文献102

同被引文献8

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部